Filing Flows

Filing Flows › Companies › Longevity Health Holdings › Cash flow

Longevity Health Holdings cash flow, quarter by quarter

Latest: Q2 2026 · from the cash-flow statements filed with the SEC

Free cash flow−$224K in Q2 2026 · −$2.4M over twelve months

Operating cash flow−$224K
Free cash flow−$224K
Cash conversion cycle-2472 days

Analysis

In Q2 2026, Longevity Health Holdings generated −$224K of operating cash flow. That is $612K more than in Q2 2025 (−$836K).

Over the twelve months to Jun 30, 2026, operating cash flow was −$2.4M; the largest uses were operating cash flow ($2.4M); besides operations, cash came from other financing ($656K), shares issued ($276K); the cash balance fell by $1.5M.

Operating cash flow was −$224K against net income of −$1.9M. The largest differences: accrued liabilities +$184K, prepaid and other assets +$116K, inventory +$89K.

Its cash conversion cycle was -2472 days (receivables 8 + inventory 380 − payables 2860): suppliers fund its working capital.

Free cash flow

Longevity Health Holdings: free cash flow by quarterLongevity Health Holdings: free cash flow by quarter−$907KQ3 2024−$1.3MQ4 2024−$753KQ1 2025−$836KQ2 2025−$1.4MQ3 2025−$306KQ4 2025−$485KQ1 2026−$224KQ2 2026
Operating cash flow less capital spending.
Longevity Health Holdings: operating cash flow against capital spendingLongevity Health Holdings: operating cash flow against capital spendingOperating cash flowCapital spending−$907K$0Q3 2024−$1.3M$0Q4 2024−$753K$0Q1 2025−$836K$0Q2 2025−$1.4M$0Q3 2025−$306K$1Q4 2025−$485K$0Q1 2026−$224K$0Q2 2026
Latest (Q2 2026): Operating cash flow −$224K, Capital spending $0.

Capital allocation, year by year

Longevity Health Holdings: where the cash came from (up) and went (down), by fiscal yearLongevity Health Holdings: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedCapital spendingAcquisitionsBuybacksFY2022: Operating cash flow −$3.4MFY2022: Net borrowing $2.7MFY2022: Shares issued $1.1MFY2022: Capital spending −$7KFY2022: Buybacks −$2K$3.8MFY2022FY2023: Operating cash flow −$8.3MFY2023: Net borrowing $1.3MFY2023: Shares issued $41KFY2023: Capital spending −$30K$1.3MFY2023FY2024: Operating cash flow −$4.4MFY2024: Net borrowing −$218KFY2024: Shares issued $2.7M$2.7MFY2024FY2025: Operating cash flow −$3.3MFY2025: Net borrowing −$441KFY2025: Shares issued $3.5MFY2025: Capital spending −$14KFY2025: Acquisitions −$150K$3.5MFY2025
Over these 4 years operating cash flow totalled −$19.5M; the largest uses were operating cash flow ($19.5M) and net borrowing ($659K). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$35K
Debtnone
Net cash$35K
Cash runway0 months

Longevity Health Holdings is burning cash: its operations consume cash, a free cash flow of −$2.4M a year at the current rate against $35K of cash and investments: a runway of about 0 months before any new financing.

Where the cash came from and went

Longevity Health Holdings: sources (+) and uses (−) of cash, Q2 2026Longevity Health Holdings: sources (+) and uses (−) of cash, Q2 2026Cash drawn (+) / kept (−)$278KOperating cash flow−$224KNet borrowing (+) / repaid (−)−$104KOther financing$50K
Longevity Health Holdings: sources (+) and uses (−) of cash, TTM to Q2 2026Longevity Health Holdings: sources (+) and uses (−) of cash, TTM to Q2 2026Operating cash flow−$2.4MCash drawn (+) / kept (−)$1.5MOther financing$656KShares issued$276KOther investing$1K

From profit to cash

Longevity Health Holdings: net income to operating cash flow, Q2 2026Longevity Health Holdings: net income to operating cash flow, Q2 2026Net income−$1.9MDepreciation & amortization$13KStock-based pay$79KReceivables$29KInventory$89KPayables−$6KAccrued liabilities$184KPrepaid and other assets$116KOperating cash flow−$224K
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q2 202683802860-2472
Q1 2026104942775-2271
Q4 202584431943-1492
Q3 2025115872351-1754
Q2 2025135782081-1489
Q1 202592781620-1332

Every quarter

QuarterOperating cash flowCapital spendingAcquisitionsNet borrowing (+) / repaid (−)Shares issuedCash drawn (+) / kept (−)Free cash flow
Q2 2026−$224K——−$104K—$278K−$224K
Q1 2026−$485K——−$98K$190K$393K−$485K
Q4 2025−$306K−$1—−$96K—$402K−$306K
Q3 2025−$1.4M——−$95K$86K$442K−$1.4M
Q2 2025−$836K——−$128K$1.8M−$781K−$836K
Q1 2025−$753K—−$150K−$122K$1.6M−$613K−$753K
Q4 2024−$1.3M——−$122K—$980K−$1.3M
Q3 2024−$907K——$342K—$1.1M−$907K

Longevity Health Holdings: income statement and cash flow

Longevity Health Holdings, Q2 2026: revenue $396K (-21% year over year), operating margin -182.9%. The chart follows the revenue to costs, profit and cash.

Longevity Health Holdings: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.